Archive

Rutgers & Posch advised the shareholders of De Jong & Laan in relation to the participation of Waterland Private Equity Investments in De Jong & Laan. This participation is the first time in the Netherlands that a private equity firm invests in the Dutch accountancy market. The team of Rutgers & Posch consisted of Lennaert Posch, Justus Fortuyn, Tijmen Noordoven, Rik Analbers and Qury van Vliet. For more…

This article by Vasco Hoving sets out the current framework for green bonds such as green securitisations and green covered bonds, which rely on green mortgage loans for their cash flows and collateral respectively. The European Taxonomy Regulation and the Delegated Climate Regulation set new requirements for the green collateral if the bonds are to qualify as European green bonds. The article provides a brief overview of what…

The Dutch Act Implementing the EU Directive on Transparent and Predictable Working Conditions will take effect on 1 August 2022. This new legislation might mean that existing employment contracts and staff handbooks will need to be updated. See the document below which schematically and point by point shows what will change as of August 1, 2022. If you need any input from the employment lawyers at Rutgers &…

Rutgers & Posch advised Dutch fintech in3 on its structured finance transaction with Waterfall Asset Management LLC. in3 provides short-term financing in the form of Buy Now, Pay Later. For more detail, please see in3’s press statement of 18 May 2022. The R&P team consisted of Maarten Ahsmann (Finance), Bas Visée (Corporate) and Kees Westermann (Finance).

Rutgers & Posch advised Accsys Technologies, a chemical technology company, on its accelerated bookbuild offering to institutional investors of €20 million. Numis Securities, Investec Bank and ABN AMRO Bank, acted as joint bookrunners. The admission to listing and trading of the new shares on Euronext Amsterdam and to trading on the Alternative Investment Market in London took place on 30 May 2022. The proceeds of the offering will…

Rutgers & Posch advised the shareholders of Medical Production Technology Europe in relation to the sale of the company to Medical Manufacturing Technologies. The team of Rutgers & Posch consisted of Lennaert Posch and Justus Fortuyn.